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Abstract
Background and objectives: Regional anesthesia is a commonly used technique in orthopedic 
procedures. Sedation should reduce the patient’s anxiety and fear while increasing regional 
anesthesia quality. This study evaluated the hemodynamic changes, level of sedation, both 
patients’ and surgeons’ levels of satisfaction and potential side effects in patient-controlled 
sedation using propofol.
Methods: This randomized clinical trial studied sixty ASA physical class I-III patients scheduled for 
total knee replacement surgery under combined spinal-epidural anesthesia. Patients in Group P 
(n = 30) received propofol via a patient-controlled analgesia device with the following settings: 
intravenous propofol bolus dose 400 μg.kg_1, 5-minute lockout interval and no basal infusion. In 
Group S, we infused saline 150 using the same settings. To determine the level of sedation, we 
used BIS and Observer’s Assessment of Alertness/ Sedation Scale. For all patients, we recorded 
the number of requests. As the ﬁ nal evaluation, we scored surgeons’ and patients’ satisfaction 
on 4-point scales.
Results: Both BIS values and OAA/S scores were lower in Group P than in Group S. Patients’ 
satisfaction was higher in Group P, although there was no signiﬁ cant difference with respect to 
surgeons’ satisfaction between the groups. The number of requests for sedation was signiﬁ cantly 
higher in Group S. However, most requests were considered unsuccessful.
Conclusion: This study suggests that patient-controlled sedation with propofol can be used 
efﬁ ciently in orthopedic procedures.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda.   
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Introduction 
Regional anesthesia is a commonly used technique in ortho-
pedic procedures. It offers several advantages, including the 
maintenance of spontaneous respiration and some patient 
reﬂ exes  such as swallowing and coughing, the provision of 
analgesia in the postoperative period, low operation costs 
and shorter hospital stays.1,2 However, as is frequently seen 
in orthopedic surgery, the patient who remains conscious 
during the procedure may be fearful, anxious, and nervous. 
The easiest way to prevent such situations is to sedate 
the patient during the operation, which should reduce the 
anxiety and fear of the patient while increasing the quality 
of regional anesthesia. However, this is quite difﬁ cult to 
achieve due to different patient expectations regarding level 
of sedation, different intraoperative conditions, and diffe-
rent pharmacokinetic and pharmacodynamics of the agents 
used. Procedural sedation, known as monitored anesthesia 
care, includes methods such as single dose, intermittent 
or continuous infusions. However, effective sedation is not 
always possible, resulting in ineffective or deep sedation.3 
Generally, anesthesiologists control the titration of sedation 
and analgesia for monitored anesthesia care procedures,4 
whereas, in patient-controlled sedation, the patients control 
their own depth of sedation under the supervision of the 
anesthesiologist. Once patients can change their levels of 
sedation in response to stress resulting from the environment 
and procedures, they are unable to use the device when they 
reach an adequate level of sedation. Thus, excessive levels 
of sedation are prevented.5,6
This study evaluated the hemodynamic changes, level of 
sedation, both patients’ and surgeons’ levels of satisfaction 
and potential side effects in patient-controlled sedation 
using propofol.
Material and Method
The Local Ethics Committee granted approval for the study. 
This randomized clinical trial included sixty ASA physical class 
I-III patients scheduled for total knee replacement surgery 
under combined spinal-epidural anesthesia.  All patients 
provided informed consent. We included patients in the 
trial if they were 53-75 years of age and excluded those that 
had vertebrae deformities, bleeding diathesis, neurological 
disorders or an allergy to the studied drug. We allocated the 
patients randomly to two groups: propofol (Group P) and 
saline solution (NS) (Group S). Patients in Group P (n = 30) 
received intravenous (IV) propofol via a patient-controlled 
analgesia (PCA) device (Abbott Pain Management Provider, 
Hospira Inc, USA) with the following settings: propofol bolus 
dose 400 μg.kg-1, 5-minute lockout interval and no basal 
infusion. In Group S, we infused NS 150 mL using the same 
settings.
Prior to the procedure, all patients received 0.9 % NS 10 
mL.kg-1 IV for prehydration and midazolam 0.025 mL.kg-1 IV 
for premedication. Each patient received detailed instruc-
tions for the use of the patient-controlled analgesia device. 
In the operating room, we applied an electrocardiogram, a 
non-invasive blood pressure monitor, a pulse oxymeter and 
BIS device (BIS Vista, Aspect Medical Systems Inc, USA) to 
each patient. We gave supplemental oxygen at a ﬂ ow rate of 
3 L.min-1 via face mask. After local anesthesia, we performed 
combined spinal-epidural block at L2-4 in the lateral decubi-
tus position and administered levobupivacaine 15 mg to the 
subarachnoid space. We placed the epidural catheter into 
the same spaces. We determined sensorial block level by the 
pin-prick test. When the level of sensorial block reached T10 
dermatome, the operation could begin. At the same time, 
patient-controlled sedation began. To determine the level 
of sedation, we used the BIS and Observer’s Assessment of 
Alertness/ Sedation Scales (OAA/SS) (Table 1). We recorded 
mean blood pressure, heart rate, peripheral oxygen satura-
tion, level of sedation and BIS values of patients every 5 mi-
nutes in the ﬁ rst 30 minutes and then at 15-minute intervals 
until 30 minutes after the end of the procedure. We termi-
nated all infusions at the end of the operation. As the ﬁ nal 
evaluation, we scored surgeons’ and patients’ satisfaction on 
4-point scales. For all patients, we recorded the number of 
requests. When the device gave the drug it was recorded as a 
successful request and when the device did not give any drug 
it was recorded as an unsuccessful request. Speciﬁ c compli-
cations noted included hemodynamic instability (systolic BP 
< 85 mm Hg), bradycardia (HR < 60.min-1), respiratory rate 
depression (< 8 breaths per minute), pain on drug injection 
and nausea or vomiting. Patients who complained of propofol 
injection pain were treated with lidocaine (20 mg bolus IV). 
We administered ephedrine 10 mg IV for hypotension and 
atropine 0.5 mg IV for bradycardia.
We performed a power analysis using Minitab 16 statistical 
package program for determining this study’s sample size. 
The study was performed with a power of at least 90% for the 
BIS values. We analyzed data with SPSS (Statistical Package 
for Social Science, SPSS Inc., Chicago, IL; USA) 11.5 package 
program (Table 2). We tested compliance with the normal 
distribution of the data obtained from the measurements 
with the Shapiro Wilk test. For the characteristics obtained 
from the measurements, descriptive statistics were connoted 
in terms of mean± standard deviation or median (minimum-
maximum) while categorical variables were connoted in 
terms of percentages. We used Student’s t or Mann Whitney 
Table 1 Assessment Scale of Patient and Surgeon 
Satisfaction.
Score Scale
0 Bad
1 Moderate
2 Good
3 Very good
                                                                                                                                         
Table 2 Demographic Data.
Group P Group S p
Age (year) 64.33 ± 6.34 65.43 ± 7.23 0.534
Body weight  (kg) 78.43 ± 6.69 82.07 ± 7.90 0.06
Body height (cm) 164.23 ± 8.76 165.13 ± 8.93 0.695
Duration of 
operation (min)
91.83 ± 19.14 88.83 ± 16.27 0.603
ASA II
ASA III
22 (73.3%)
8 (26.7%)
25 (83.3%)
5 (16.7%)
0.347
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U test to determine whether there was any statistically 
signiﬁ cant difference between the data obtained from both 
groups. We used Repetitive Measurement Variance Analysis 
or the Friedman test to determine whether there were 
statistically signiﬁ cant differences between the recurrent 
measurements conducted on both groups. In cases where we 
found Repetitive Measurement Variance Analysis or Friedman 
test results to be signiﬁ cant, we applied the Bonferroni 
Corrected Multiple Comparison test to determine the time 
of the measurement which had caused the difference. We 
presented results related to all intragroup comparisons after 
Bonferroni Correction. For categorical comparisons, we used 
Chi-square and Fisher’s Deﬁ nitive test. We accepted a value 
of p < 0.05 as statistically signiﬁ cant.
Results
Patient-controlled sedation with propofol was applied to 
patients undergoing orthopedic surgery under regional 
anesthesia. The following results were determined from 
this study: Both BIS values and OAA/S scores were lower in 
Group P than in Group S. Patients’ satisfaction was higher in 
Group P. However, there was no signiﬁ cant difference with 
respect to surgeons’ satisfaction between the groups. The 
characteristics of age, body weight and height, duration of 
surgery and ASA scores were similar in both groups. The mean 
propofol dosage used in Group P was 132.87 ± 62.6 mg. We 
administered no additional sedative drug in group S. There 
was no statistical difference between the groups in terms 
of heart rate, mean blood pressure and peripheral oxygen 
saturation. However, the BIS values and OAA/S scores were 
lower in Group P than in Group S.  Patients’ satisfaction scores 
were higher in Group P in comparison with those in Group S. 
However, surgeons’ satisfaction scores were similar for both 
groups. While 76.7% of patients complained of injection pain 
in Group P, there were no complaints from Group S. We saw 
hypotension and bradycardia in Group P patients at the rate 
of 16.7% and 13.3%, respectively. In Group S, we observed 
bradycardia in only 10% of patients. The number of requests 
for sedation was signiﬁ cantly higher in Group S, but most of 
these were considered unsuccessful requests (Table 3). 
Discussion
Central neuraxial blockade techniques are widely accepted 
and used with conﬁ dence by anesthesiologists. Stress factors 
in the operating room and ineffective or patchy blocks may 
result in discomfort and anxiety in patients under regional 
anesthesia. Thus, a sufﬁ ciently sedated and cooperative 
patient is of great importance in regional anesthesia.7 
Anesthesiologists frequently use sedative and narcotic agents 
in operating rooms in order to resolve anxiety and fear;8 ho-
wever, the different responses of patients to these drugs may 
result in ineffective or deep sedation. In addition, patients’ 
requests regarding the level of sedation vary dramatically - 
some patients prefer to be awake during the whole operation, 
while most prefer deep sedation so as not to remember what 
happens during the procedure.
Traditionally, the anesthesiologists in monitored anes-
thesia care perform titration of sedation. However, in 
patient-controlled sedation, patients are free to control their 
own levels of sedation. The purpose of patient-controlled 
sedation is to achieve fast and adequate sedation without 
risk of overdose.9 Sedation with propofol has been advocated 
as an alternative to the more commonly used combination 
of midazolam and narcotic sedative drugs. Propofol is asso-
ciated with faster onset and offset of sedation and higher 
patient satisfaction. Patient-controlled sedation has been 
advocated to improve titration of sedation with propofol. 
In a study of elderly patients that underwent cataract sur-
gery, Yun et al. determined that the use of propofol in both 
anesthesiologist-controlled and patient-controlled sedation 
reduced anxiety and that patients’ satisfaction was higher in 
the patient-controlled group.10 Singh et al. applied patient-
controlled and anesthesiologist-controlled sedation with 
propofol to patients during surgery under spinal anesthesia 
and determined that the patient-controlled model resulted in 
effective sedation with lower propofol dosage, and that the 
respiratory depression rate was lower in the same model.11 
Crepeau et al. used propofol in both patient-controlled and 
anesthesiologist-controlled sedation during colonoscopy and 
determined that propofol was a highly effective sedative 
agent in the patient-controlled method.12
Wilson et al. determined that propofol and midazolam 
used in addition to spinal anesthesia resulted in adequate se-
dation, and that recovery was more rapid with propofol.13
Yaddanupi et al. compared propofol and midazolam in-
fusions in elderly patients who underwent urological surgery 
under spinal anesthesia. With a propofol bolus of 0.4mg.kg-1 
and 3mg.kg-1.h-1 infusion, titration and efﬁ ciency of sedation 
were improved, but resulted in hypotension.14 Mandel et al. 
compared propofol-remifentanil and midazolam-fentanyl 
combinations using the patient-controlled sedation method 
on patients during colonoscopy, and determined that the 
propofol-remifentanil combination was superior.15
Although patient-controlled analgesia is a commonly used 
method for orthopedic patients undergoing hip or knee repla-
cement surgery in our hospital, patient-controlled sedation 
Table 3 Number of Requests.
Mean ± SD Minimum Maximum
Group P   
   Successful PCA
   Unsuccessful PCA
   Total PCA 
4.30 ± 2.10
6.30 ± 5.24
10.60 ± 6.55
1
1
2
9
22
27
Group S  
   Successful PCA
   Unsuccessful  PCA
   Total PCA
6.70 ± 2.87
23.33 ± 18.39
30.03 ± 19.57
1
2
3
13
69
77
PCA, patient-controlled analgesia/sedation.
Table 4 Side Effects.
Group P Group S p
Bradycardia 4 (13.3%) 3 (10%) 1.000
Hypotension 5 (16.7%) - 0.052
Nausea - - -
Vomiting - - -
Respiratory depression - - -
Injection pain 23 (76.7%) - 0.000*
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is not routinely implemented. However, the orthopedic 
operating rooms allow noise of up to 110 decibels, so it is 
clear that patient-controlled sedation can be applied easily 
and safely in orthopedic procedures.
In this study, patient-controlled sedation was applied to 
patients who underwent knee replacement surgery under 
combined spinal-epidural anesthesia. The average propofol 
dosage used in patient-controlled sedation was 132.87 ± 
62.6 mg. However, total propofol dosage used in the patient-
controlled sedation differs according to the type and dura-
tion of the surgery and the patient group. Ganapaty et al. 
reported average propofol dosage of 190.0 ± 92.3 in knee 
and hip replacement surgery under regional anesthesia.16 
Crepeau et al. reported 60 mg dosage in patient-controlled 
sedation for colonoscopy12 but Ng et al.17 reported 98 mg 
dosage. While Yun et al. reported a dosage of 30.1 ± 30.4 
mg for patient-controlled sedation in cataract surgery,10 
Janzen et al. reported 40.8 ± 35.9 mg.18 Ganapaty et al. 
reported patient-controlled propofol usage as 25 μg.kg-1.
min-1, whereas the present study found it to be 18 μg.kg-1.
min-1. The one-minute propofol dosage used in this study was 
lower than that reported in the study by Ganapaty and also 
lower than the 30–60 μg.kg-1.min-1, which has been sugges-
ted for sedation. The authors consider one-minute propofol 
dosage to be affected by the duration of the operation and 
midazolam premedication. Nakagawa et al. reported that 
midazolam premedication reduced the propofol requirement 
for sedation.19
In this study, we used BIS monitoring to determine the 
level of sedation. Although the sensitivity of BIS in terms of 
monitoring of the level of sedation has been approved in many 
studies,20-22 the issue remains controversial.23 Therefore, in 
order to eliminate potential misevaluations, we also used 
the clinical observational method of OAA/SS to evaluate 
the level of sedation. BIS values decreased 15 minutes after 
the beginning of sedation and increased gradually after the 
termination of sedation. We observed ﬂ uctuations in OAA/S 
scores in parallel to those of BIS values. BIS values remained 
in the alertness range during the operation and never fell 
below 80, and no deep sedation episode occurred. High BIS 
values resulted from high environmental stimuli and the ap-
plication of the tourniquet. These partly high BIS values did 
not have a negative effect on the patients’ satisfaction as 30% 
of the patients in Group P classed the method as good while 
70% classed it as very good. Another indicator of patients’ 
satisfaction was the number of requests for sedation. In the 
patient-controlled sedation group, the average number of 
requests was 10.6 ± 6.5. Successful requests were deter-
mined as 40%. The current study’s ﬁ ndings are comparable 
with those of Ganapaty et al., who reported satisfaction and 
successful request rates as 94% and 43.8%, respectively.16 
We observed no signiﬁ cant difference in the patients 
of Group S when compared to initial BIS values, and we 
determined the requests for sedation as 30.0 ± 19.6 (22% 
successful). These ﬁ ndings show that the preoperative use 
of midazolam for premedication is not sufﬁ cient for perio-
perative sedation.
We observed injection pain in 76.7% of patients in Group 
P. Ganapaty et al reported a rate of 80%.16 This rate is quite 
high for the patient-controlled sedation group and should be 
considered a problem to be resolved.
We observed hypotension in 17% of the patients in Group 
P. Although no statistically signiﬁ cant difference was found 
when compared with the patients in Group S, this shows an 
important side effect to be considered (Table 4). The one-
minute propofol dosage in the patient-controlled sedation 
in the current study was lower than in previous studies. 
However, the dosages were not adjusted according to the 
age of the patient. In patient-controlled sedation, propofol 
dosage should be reduced for elderly patients.
The results of this study determined that propofol redu-
ces BIS values and OAA/S scores does not negatively impact 
satisfaction levels for patients or surgeons, does not lead to 
side effects other than injection pain and that midazolam 
premedication alone is not sufﬁ cient for perioperative seda-
tion. These ﬁ ndings suggest that patient-controlled sedation 
with propofol can be used efﬁ ciently in orthopedic proce-
dures and that the routine use of this method will increase 
patients’ comfort under regional anesthesia.
Conﬂ icts of interest
The authors declare no conﬂ icts of interest.
References
1.  Kol Ö - Spinal anestezi altındaki ürolojik endoskopik girişimlerde 
hasta kontrollü sedasyon uygulamalarının karşılaştırılması 
(uzmanlık tezi), C.Ü. Tıp Fakültesi, 2002.
2.  Reves GJ, Glass SA, Lubarsky DA - Non-barbiturate intravenous 
anesthetics. In Miller RD (Ed.), Anesthesia. 4th ed. New York: 
Churchill Livingstone, 1994, p. 269-274.
3.  Barash PG, Cullen BF, Stoelting RK - Clinical anesthesia. 4th ed. 
Philadelphia:  Lippincoth, William & Wilkins, 2001.
4.  Alhashemi AJ, Kaki AM - Anesthesiologist-controlled versus 
patient-controlled propofol sedation for shockwave lithotripsy. 
Can J Anesth. 2006;53(5):449-455.
5.  Gillham MJ, Hutchinson RC, Carter R et al. - Patient-maintained 
sedation for ERCP with a target-controlled infusion of propofol: 
a pilot study. Gastrointest Endocs. 2001;54:14-17.
6.  Irwin MG, Thompson N, Kenney GNC - Patient-maintained 
propofol sedation: assessment of a target-controlled infusion 
system. Anaesthesia. 1997;54:525-530.
7.  Tripathi M, Nath SS, Chaudhary A et al. - Patient controlled 
sedation during neuraxial anesthesia. J Postgrad Med. 
2009;55(2):108-112.
8.  Urmey WF - Combined spinal-epidural anesthesia for orthopedic 
surgery. Techniques in Regional Anesthesia and Pain Management. 
1997;1:123-130.
9.  Thorpe SJ, Balakrishnan VR, Cook LB - The safety of patient-
controlled sedation. Anaesthesia. 1997;52(12):1144-1150.
10.  Yun MJ, Oh AY, Kim KO et al. - Patient-controlled sedation vs. 
anaesthetic nurse-controlled sedation for cataract surgery in 
elderly patients. Int J Clin Pract. 2008;62(5):776-780. 
11.  Singh T, Ravishankar M - Conscious sedation with propofol for 
surgeries under spinal anaesthesia: anaesthesiologist versus 
patient controlled. J Anaesth Clin Pharmacol. 2005;21(2):169-
173.
12.  Crepeau T, Poincloux L, Bonny C - Signiﬁ cance of patient-
controlled sedation during colonoscopy. Gastroenterol Clin Biol. 
2005;29:1090-1096.
13.  Wilson E, David A, Mackenzie N et al. - Sedation during spinal 
anaesthesia: comparison of propofol and midazolam. Br J 
Anaesth. 1990;64:48-52.
414 Ekin A. et al.
14.  Yaddanapudi S, Batra YK, Balagopal A et al. - Sedation in patient 
above 60 years of age undergoing urological surgery under spinal 
anesthesia: comparison of propofol and midazolam infusions. J 
Postgrad Med. 2007;53(3):171-175.
15.  Mandel JE, Tanner JW, Lichtenstein GR - A randomized, 
controlled, double-blind trial of patient-controlled sedation 
with propofol/remifentanil versus midazolam/fentanyl for 
colonoscopy. Anesth Analg. 2008;106:434-439.
16.  Ganapaty S, Herrick I - Propofol patient-controlled sedation 
during hip or knee arthroplasty in elderly patients. Can J Anaest. 
1997;44(4):385-389.
17.  Ng JM, Kong CF, Nyam D - Patient-controlled sedation with 
propofol for colonoscopy. Gastrointest Endosc. 2001;54:8-13.
18.  Janzen PRM, Christys A, Vucevic M - Patient-controlled sedation 
using propofol in elderly patients in day-case cataract surgery. 
Br J of Anaesth. 1999;82(4):635-636.
19.  Nakagawa M, MammotoT - Midazolam premedication reduces 
propofol requirements for sedation during regional anesthesia. 
Can J Anesth. 2000:47(1):47-49.
20.  Lui J, Singh H, White PF - Electroencephalogram bispectral 
analysis predicts the depth of midazolam-induced sedation. 
Anesthesiology. 1996;84:64-69.
21.  Glass P, Blomm M, Kearse L - Bispectral analysis measures 
sedation and memory effects of propofol, midazolam, 
isoﬂ urane, and alfentanyl in healthy volunteers. Anesthesiology. 
1997;86:836-847.
22.  Lui J, Singh H, White PF - Electroencephalographic bispectral 
index correlates with intraoperative recall and depth of 
propofol-induced sedation. Anesth Analg. 1997;84:185-189.
23.  Iselin-Chaves IA, Flaishon R, Sebel PS et al. - The effect of 
the interaction of propofol and alfentanyl on recall, loss 
of consciousness, and the bispectral index. Anesth Analg. 
1998;87:949-955.
